Dipna Pharmachem (BOM:543594) EV-to-EBIT : 7.30 (As of Sep. 26, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dipna Pharmachem's Enterprise Value is ₹250 Mil. Dipna Pharmachem's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34 Mil. Therefore, Dipna Pharmachem's EV-to-EBIT for today is 7.30.

The historical rank and industry rank for Dipna Pharmachem's EV-to-EBIT or its related term are showing as below:

BOM:543594' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.65 Med: 11.03 Max: 21.99
Current: 7.3

During the past 5 years, the highest EV-to-EBIT of Dipna Pharmachem was 21.99. The lowest was 6.65. And the median was 11.03.

BOM:543594's EV-to-EBIT is ranked better than
85.59% of 444 companies
in the Healthcare Providers & Services industry
Industry Median: 18.03 vs BOM:543594: 7.30

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Dipna Pharmachem's Enterprise Value for the quarter that ended in Mar. 2024 was ₹282 Mil. Dipna Pharmachem's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34 Mil. Dipna Pharmachem's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 12.16%.

Dipna Pharmachem EV-to-EBIT Historical Data

The historical data trend for Dipna Pharmachem's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem EV-to-EBIT Chart

Dipna Pharmachem Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-EBIT

10.75

8.22

Dipna Pharmachem Semi-Annual Data
	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial			-	-	10.75	-	8.22

Competitive Comparison of Dipna Pharmachem's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dipna Pharmachem's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dipna Pharmachem's EV-to-EBIT falls into.

Dipna Pharmachem EV-to-EBIT Calculation

Dipna Pharmachem's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	250.435	/	34.312
	=	7.30

Dipna Pharmachem's current Enterprise Value is ₹250 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dipna Pharmachem's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34 Mil.

Dipna Pharmachem (BOM:543594) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Dipna Pharmachem's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	34.312	/	282.173784
	=	12.16 %

Dipna Pharmachem's Enterprise Value for the quarter that ended in Mar. 2024 was ₹282 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dipna Pharmachem's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34 Mil.

Dipna Pharmachem EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Dipna Pharmachem's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Dipna Pharmachem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380 055

Website

https://www.dipnapharmachem.com

Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone and others.

Dipna Pharmachem Headlines

No Headlines